Evidence map›Paper›PMID 34774811›Full record

ArticleMolecular metabolism2021

Targeting the cytoplasmic polyadenylation element-binding protein CPEB4 protects against diet-induced obesity and microbiome dysbiosis.

Nuria Pell, Ester Garcia-Pras, Javier Gallego, Salvador Naranjo-Suarez, Alexandra Balvey, Clara Suñer, Marcos Fernandez-Alfara, Veronica Chanes, Julia Carbo, Marta Ramirez-Pedraza and 10 more

Abstract read
In one paragraph

Article in Molecular metabolism, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Molecular Effects of Physical Activity and Body Composition: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2025
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Genome-wide screening for genetic variants in polyadenylation signal (PAS) sites in mouse selection lines for fatness and leanness.Mammalian genome : official journal of the International Mammalian Genome Society · 2023
    Article
  12. Review
  13. Translational Control in Liver Disease.Frontiers in physiology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Nuria PellIDIBAPS Biomedical Research Institute, University of Barcelona, Barcelona, Spain.
Ester Garcia-PrasIDIBAPS Biomedical Research Institute, University of Barcelona, Barcelona, Spain.
Javier GallegoIDIBAPS Biomedical Research Institute, University of Barcelona, Barcelona, Spain.
Salvador Naranjo-SuarezIDIBAPS Biomedical Research Institute, University of Barcelona, Barcelona, Spain.
Alexandra BalveyIDIBAPS Biomedical Research Institute, University of Barcelona, Barcelona, Spain.
Clara SuñerInstitute for Research in Biomedicine (IRB), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Marcos Fernandez-AlfaraInstitute for Research in Biomedicine (IRB), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Veronica ChanesInstitute for Research in Biomedicine (IRB), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Julia CarboIDIBAPS Biomedical Research Institute, University of Barcelona, Barcelona, Spain.
Marta Ramirez-PedrazaIDIBAPS Biomedical Research Institute, University of Barcelona, Barcelona, Spain.
Oscar ReinaInstitute for Research in Biomedicine (IRB), The Barcelona Institute of Science and Technology, Barcelona, Spain.
Louise ThingholmInstitute of Clinical Molecular Biology, Christian-Albrechts-University Kiel, University Hospital Schleswig Holstein Campus Kiel, Kiel, Germany.
Corinna BangInstitute of Clinical Molecular Biology, Christian-Albrechts-University Kiel, University Hospital Schleswig Holstein Campus Kiel, Kiel, Germany.
Malte RühlemannInstitute of Clinical Molecular Biology, Christian-Albrechts-University Kiel, University Hospital Schleswig Holstein Campus Kiel, Kiel, Germany.
Andre FrankeInstitute of Clinical Molecular Biology, Christian-Albrechts-University Kiel, University Hospital Schleswig Holstein Campus Kiel, Kiel, Germany.
Robert SchierwagenGoethe University Frankfurt, Frankfurt, Germany.
Karl P RheinwaltFranziskus Krankenhaus, Cologne, Germany.
Jonel TrebickaGoethe University Frankfurt, Frankfurt, Germany.
Raul MendezInstitute for Research in Biomedicine (IRB), The Barcelona Institute of Science and Technology, Barcelona, Spain; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.
Mercedes FernandezIDIBAPS Biomedical Research Institute, University of Barcelona, Barcelona, Spain. Electronic address: mercefernandez@ub.edu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveObesity represents a growing health problem that is reaching pandemic dimensions and lacks effective cures, thus highlighting an urgent need for better mechanistic understanding and new therapeutic strategies. Unlike transcription, the function of translation in obesity has hardly been investigated. Here, we fill this knowledge gap by pinpointing a crucial function for gene regulation at the step of translation in diet-induced obesity.

methodsWe performed studies with human adipose tissue, high-fat-diet-induced obese mice and rats, CPEB4-knockout mice, and adipocyte lines. Cells were transfected with small-interfering RNAs that knockdown CPEB4. Transcriptome-wide identification and validation of CPEB4 targets in adipocytes were obtained by RNA-protein coimmunoprecipitation and high-throughput sequencing. The effect of CPEB4 depletion on high-fat-diet-induced dysbiosis was determined by 16S ribosomal-RNA gene sequencing and microbiome bioinformatics.

resultsWe show that cytoplasmic polyadenylation element-binding protein 4 (CPEB4), which controls the translation of specific mRNAs by modulating their poly(A) tails, is highly expressed in visceral fat of obese but not lean humans and rodents (mice and rats), where it orchestrates an essential post-transcriptional reprogramming for aggravation of high-fat-diet-induced obesity. Mechanistically, CPEB4 overexpression in obese adipocytes activates the translation of factors essential for adipose tissue expansion (Cebpb, Stat5a) and adipocyte-intrinsic immune-like potential (Ccl2, Tlr4), as demonstrated by RNA-immunoprecipitation and high-throughput sequencing and experimentally validated in vivo. Consistently blocking CPEB4 production in knockout mice protects against diet-induced body weight gain and reduces adipose tissue enlargement and inflammation. In addition, the depletion of CPEB4 specifically in obese adipocytes using short hairpin RNAs decreases cell differentiation, lipid accumulation, and the proinflammatory and migratory capacity of macrophages. The absence of CPEB4 also attenuates high-fat diet-induced dysbiosis, shaping the microbiome composition toward a more beneficial profile, as shown by microbiome bioinformatics analysis.

conclusionOur study identifies CPEB4 as a driver and therapeutic target to combat obesity.

Indexed as

AdultDiet, High-FatDysbiosisFemaleGastrointestinal MicrobiomeHumansMaleObesityPolyadenylationRNA-Binding ProteinsCPEB4 protein, humanRNA-Binding ProteinsAdipose tissueMicrobiome dysbiosisObesityRNA-Binding proteinsTranslation

Identifiers

PMID34774811
PMCPMC8711066

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.